常见产品
Common Products
相关产品
CAS:97148-38-4|E-Ceftazidime
- 产品货号:E-2024050112
- 发布时间:2024-05-21
- 产品CAS :97148-38-4
- 产品规格:mg(更多包装需求请咨询客服)
- 产品纯度:95%+
- 产品货期:现货下单后48小时内发货,定制产品4-8周。
- 运输条件:顺丰常规运输
产品详情
货号:E-2024050112
CAS:97148-38-4
规格:mg(更多包装需求请咨询客服)
纯度:95%+
生产商:试剂家
试剂家(www.empireagents.com) - 瑞禧生物旗下试剂品牌。致力于为全球客户提供高性价比的助力药物递送的产品服务。公司的奋斗目标是搭建一个国际知名的药物递送修饰平台,携手高端人才和所有合作伙伴,共同为人类各行各业的事业发展做出贡献!
Catalogue Number:C244125
Chemical Name:E-Ceftazidime
Synonyms:(6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Ceftazidime Impurity B
CAS Number:97148-38-4
Molecular Formula:C₂₂H₂₂N₆O₇S₂
Appearance:Pale Brown to Light Brown Solid
Melting Point:>105°C (dec.)
Molecular Weight:546.58
Storage:-20°C
Solubility:DMSO (Slightly), Methanol (Slightly, Sonicated)
Stability
Hygroscopic
Category:Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Applications:E-Ceftazidime is an impurity of Ceftazidime Pentahydrate (C244100)
References:Brodie, A., et al.: Antimicrob. Agents Chemother., 17, 876 (1980); Richards, D.M., et al.: Drugs, 29, 105 (1985); Abounassif, M.A., et al.: Anal. Profiles Drug Subs., 19, 95 (1990)试剂家(www.empireagents.com)从未停止过技术的拓展与创新。凭借这充满进取的创新精神,我们已经为国内外高校、科研单位、材料研究中心、生物技术制药开发公司等等定制合成了各种功能化试剂,赢得了合作单位的长期信赖。
更多产品推荐:
CAS:180854-85-7|2-Chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide
CAS:134-83-8|1-Chloro-4-(chlorophenylmethyl)benzene
CAS:37945-06-5|5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone
CAS:469-61-4|(-)-a-Cedrene (major, contains (+)-b-cedrene)
CAS:54643-79-7|6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid
CAS:546-28-1|(+)-β-Cedrene (major, contains (-)-cedrene)
CAS:546-28-1|(+)-β-Cedrene
CAS:103877-20-9|7-Chloro-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic Acid
CAS:101987-89-7|8-Chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
CAS:67762-27-0|Cetearyl Alcohol
在线留言
欢迎您访问“试剂家 | 纳米靶向科研平台”官方网站,请留下您的需求,我们会派专业人员及时与您联系,并为您提供相应的产品方案。